Fortis Healthcare Limited
Fortis Healthcare Limited (FORTIS) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Services›Hospital
fortishealthcare.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Stock price
₹917.50
Market cap
69,239 Cr
Stock P/E
73.8
P/B
6.81
Dividend yield
0.1%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,770 Cr | 1,680 Cr | 1,786 Cr | 1,859 Cr | 1,988 Cr | 1,928 Cr | 2,007 Cr | 2,167 Cr | 2,331 Cr | 2,265 Cr | 2,365 Cr | 2,545 Cr |
| Operating expenses (approx.) | 1,440 Cr | 1,396 Cr | 1,405 Cr | 1,516 Cr | 1,554 Cr | 1,553 Cr | 1,572 Cr | 1,676 Cr | 1,775 Cr | 1,759 Cr | 1,832 Cr | 2,008 Cr |
| EBITDA | 330 Cr | 284 Cr | 381 Cr | 343 Cr | 435 Cr | 375 Cr | 435 Cr | 491 Cr | 556 Cr | 506 Cr | 532 Cr | 537 Cr |
| OPM % | 18.7% | 16.9% | 21.3% | 18.4% | 21.9% | 19.5% | 21.7% | 22.6% | 23.9% | 22.3% | 22.5% | 21.1% |
| Other income | 14 Cr | 7 Cr | 10 Cr | 13 Cr | 13 Cr | 21 Cr | 20 Cr | 15 Cr | 23 Cr | 8 Cr | 4 Cr | 14 Cr |
| Interest | 32 Cr | 33 Cr | 35 Cr | 35 Cr | 36 Cr | 45 Cr | 68 Cr | 70 Cr | 75 Cr | 86 Cr | 84 Cr | 80 Cr |
| Depreciation | 84 Cr | 87 Cr | 92 Cr | 91 Cr | 95 Cr | 97 Cr | 102 Cr | 101 Cr | 106 Cr | 120 Cr | 122 Cr | 122 Cr |
| Profit before tax | 233 Cr | 183 Cr | 271 Cr | 230 Cr | 261 Cr | 279 Cr | 237 Cr | 351 Cr | 425 Cr | 266 Cr | 324 Cr | 363 Cr |
| Tax % | 21.0% | 26.7% | 25.1% | 24.4% | 26.0% | 9.0% | 20.5% | 23.9% | 22.7% | 25.7% | 16.4% | 24.9% |
| Net profit | 184 Cr | 134 Cr | 203 Cr | 174 Cr | 193 Cr | 254 Cr | 188 Cr | 267 Cr | 329 Cr | 197 Cr | 271 Cr | 273 Cr |
| EPS (₹) | ₹2.30 | ₹1.78 | ₹2.37 | ₹2.20 | ₹2.34 | ₹3.28 | ₹2.44 | ₹3.45 | ₹4.26 | ₹2.57 | ₹3.52 | ₹3.53 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,469 Cr | 4,632 Cr | 4,030 Cr | 5,718 Cr | 6,298 Cr | 6,893 Cr | 7,783 Cr | 9,128 Cr | Sign in for TTM |
| Operating expenses (approx.) | 4,244 Cr | 4,023 Cr | 3,626 Cr | 4,649 Cr | 5,196 Cr | 5,625 Cr | 6,195 Cr | 7,043 Cr | Sign in for TTM |
| EBITDA | 225 Cr | 610 Cr | 404 Cr | 1,069 Cr | 1,101 Cr | 1,268 Cr | 1,588 Cr | 2,085 Cr | Sign in for TTM |
| OPM % | 5.0% | 13.2% | 10.0% | 18.7% | 17.5% | 18.4% | 20.4% | 22.8% | Sign in for TTM |
| Other income | 92 Cr | 53 Cr | 47 Cr | 27 Cr | 62 Cr | 38 Cr | 67 Cr | 51 Cr | Sign in for TTM |
| Interest | 337 Cr | 205 Cr | 166 Cr | 147 Cr | 129 Cr | 131 Cr | 184 Cr | 314 Cr | Sign in for TTM |
| Depreciation | 233 Cr | 292 Cr | 291 Cr | 301 Cr | 316 Cr | 343 Cr | 386 Cr | 449 Cr | Sign in for TTM |
| Profit before tax | -110 Cr | 239 Cr | 43 Cr | 988 Cr | 814 Cr | 858 Cr | 1,007 Cr | 1,366 Cr | Sign in for TTM |
| Tax % | -103.2% | 61.8% | 229.8% | 20.0% | 22.2% | 24.8% | 19.6% | 22.1% | Sign in for TTM |
| Net profit | -224 Cr | 91 Cr | -56 Cr | 790 Cr | 633 Cr | 645 Cr | 809 Cr | 1,064 Cr | Sign in for TTM |
| EPS (₹) | ₹-3.70 | ₹0.77 | ₹-1.45 | ₹7.35 | ₹7.80 | ₹7.93 | ₹10.26 | ₹13.80 | Sign in for TTM |
| Dividend payout % | — | — | — | 0.0% | 2.5% | 13.3% | 13.5% | 7.3% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 755 Cr | 754 Cr | 755 Cr | 755 Cr | 755 Cr | 755 Cr | 755 Cr | 755 Cr |
| Reserves | 5,846 Cr | 5,906 Cr | 5,365 Cr | 5,423 Cr | 6,487 Cr | 6,908 Cr | 8,162 Cr | 9,141 Cr |
| Borrowings | — | — | — | — | 926 Cr | 858 Cr | 2,475 Cr | 2,873 Cr |
| Other liabilities | 5,350 Cr | 4,688 Cr | 5,035 Cr | 5,707 Cr | 3,407 Cr | 3,874 Cr | 2,047 Cr | 2,925 Cr |
| Total liabilities | 11,951 Cr | 11,348 Cr | 11,155 Cr | 11,885 Cr | 12,434 Cr | 13,289 Cr | 13,692 Cr | 15,966 Cr |
| Fixed assets (net) | — | — | — | — | 4,850 Cr | 5,268 Cr | 5,848 Cr | 5,348 Cr |
| CWIP | — | — | — | — | 228 Cr | 540 Cr | 404 Cr | 432 Cr |
| Investments | — | — | — | — | 210 Cr | 230 Cr | 169 Cr | 1,782 Cr |
| Loans & advances | — | — | — | — | 2 Cr | 2 Cr | 2 Cr | 2 Cr |
| Inventories | — | — | — | — | 123 Cr | 107 Cr | 115 Cr | 135 Cr |
| Trade receivables | — | — | — | — | 582 Cr | 628 Cr | 784 Cr | 1,044 Cr |
| Cash & bank | — | — | — | — | 141 Cr | 235 Cr | 140 Cr | 407 Cr |
| Other assets | 11,951 Cr | 11,348 Cr | 11,155 Cr | 11,885 Cr | 6,299 Cr | 6,279 Cr | 6,229 Cr | 6,815 Cr |
| Total assets | 11,951 Cr | 11,348 Cr | 11,155 Cr | 11,885 Cr | 12,434 Cr | 13,289 Cr | 13,692 Cr | 15,966 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 865 Cr | 822 Cr | 1,100 Cr | 1,424 Cr | 1,602 Cr |
| Cash from investing | — | — | — | -514 Cr | -374 Cr | -886 Cr | -779 Cr | -1,538 Cr |
| Cash from financing | — | — | — | -517 Cr | -471 Cr | -86 Cr | -714 Cr | 164 Cr |
| Net cash flow | — | — | — | -166 Cr | -21 Cr | 125 Cr | -70 Cr | 228 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 650 Cr | 375 Cr | 158 Cr | 577 Cr | 656 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 3.4% | 6.7% | 3.4% | 18.4% | 10.4% | 10.5% | 10.2% | 12.9% |
| ROE % | -3.4% | 2.0% | -1.8% | 9.0% | 7.3% | 7.0% | 8.4% | 10.2% |
| Debtor days | — | — | — | — | 34 | 33 | 37 | 42 |
| Inventory days | — | — | — | — | 7 | 6 | 5 | 5 |
| Days payable | — | — | — | — | 41 | 39 | 38 | 38 |
| Cash conversion cycle | — | — | — | — | -1 | 0 | 4 | 9 |
| Debt / equity | — | — | — | — | 0.13 | 0.11 | 0.28 | 0.29 |
| Current ratio | — | — | — | — | 1.39 | 0.69 | 1.35 | 0.86 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 0.71 | 0.49 | 1.47 | 1.18 |
Compare with peers
Loading peers…